Analyst calls: LinkedIn upgraded
Riverbed is downgraded at 2 firms, and Activision Blizzard is upgraded to 'outperform.'
Friday's noteworthy upgrades include:
- ARM Holdings (ARMH) upgraded to Outperform from Neutral at Credit Suisse
- AvalonBay (AVB) upgraded to Buy from Neutral at UBS
- Barclays (BCS) upgraded to Neutral from Underperform at Macquarie
- Biogen (BIIB) upgraded to Buy from Neutral at Citigroup
- Discover (DFS) upgraded to Outperform from Neutral at Credit Suisse
- MetroPCS (PCS) upgraded to Neutral from Reduce at Nomura
- Manulife Financial (MFC) upgraded to Sector Outperformer from Sector Performer at CIBC
- Guess (GES) upgraded to Outperform from Neutral at Wedbush
- LinkedIn (LNKD) upgraded to Buy from Outperform at CLSA
- Activision Blizzard (ATVI) upgraded to Outperform from Neutral at Macquarie
- Alpha Natural (ANR) downgraded to Fair Value from Buy at CRT Capital
- Riverbed (RVBD) downgraded to Market Perform from Outperform at FBR Capital, and to Neutral from Buy at Lazard Capital
- Teva (TEVA) downgraded to Hold from Buy at Canaccord
- Bunge (BG) downgraded to Hold from Strong Buy at Feltl
- Deere (DE) downgraded to Buy from Strong Buy at ISI Group
- Cummins (CMI) downgraded to Buy from Strong Buy at ISI Group
- Oshkosh (OSK) downgraded to Buy from Strong Buy at ISI Group
- Gartner (IT) downgraded to Neutral from Overweight at Piper Jaffray
- Affymax (AFFY) initiated with an Outperform at JMP Securities
- Celgene (CELG) initiated with an Outperform at JMP Securities
- DSW (DSW) initiated with a Buy at Sterne Agee
- Onyx Pharmaceuticals (ONXX) initiated with an Outperform at JMP Securities
- VeriFone (PAY) initiated with a Hold at Jefferies... sZebra Technologies
- ARIAD (ARIA) initiated with an Outperform at JMP Securities
- Motorola Solutions (MSI) initiated with an Outperform at Wells Fargo
Copyright © 2014 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
Puma Biotechnology shares soar after it says it wants to file for marketing approval of an experimental breast cancer drug.
VIDEO ON MSN MONEY
Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.
Contributors include professional investors and journalists affiliated with MSN Money.
Follow us on Twitter @topstocksmsn.